期刊文献+

血清内脂素水平与慢性稳定性冠心病的关系 被引量:8

Relationship Between Serum Level of Visfatin and Chronic Stable Coronary Artery Disease
下载PDF
导出
摘要 目的评价外周血清内脂素水平与慢性稳定性冠心病的相关性。方法 76例住院患者根据冠状动脉造影结果和临床表现分为慢性稳定性冠心病组(n=54)和非冠心病组(n=22)。用酶联免疫吸附法测定血清内脂素水平。比较两组临床资料及血清内脂素水平的差异。分析内脂素水平的影响因素。用Logistic回归模型分析血清内脂素水平与慢性稳定性冠心病的相关性。结果慢性稳定性冠心病组的血清内脂素水平的中位数为2.79μg/L(2.03μg/L,5.08μg/L),明显高于非冠心病组[2.54μg/L(1.48μg/L,2.97μg/L)](P=0.040)。多变量线性回归分析显示,慢性稳定性冠心病组血清内脂素水平受高敏C反应蛋白的影响(β=0.458,95%CI 0.065~0.308,P=0.004)。Logistic回归分析显示,血清内脂素水平是慢性稳定性冠心病的一个独立危险因素(OR 2.086,95%CI 1.046~4.160,P=0.037)。结论血清内脂素水平在慢性稳定性冠心病患者中明显升高,可能与该疾病的发生密切相关。 Aim To evaluate the relationship between visfatin level of peripheral blood and chronic stable coronary artery disease (SCAD). Methods According to the result of coronary angiography and clinical presentation, 76 patients were divided into two groups: chronic SCAD group (n = 54) with significant coronary stenosis and non-CAD group (n = 22 ) without significant lesions. Serum level of visfatin was measured by enzyme-linked immunosorbent assay (ELISA). The differences of clinical data and serum visfatin level in the two groups were compared. The factors affecting visfatin level were analyzed. The correlation between serum level of visfatin and chronic SCAD was analyzed by Logistic regression model. Results Serum level of visfatin was significantly higher in the chronic SCAD group [ 2. 79 μg/L (2. 03 μg/L, 5.08μg/L) ] than that in the non-CAD group [2. 54 μg/L (1.48 μg/L, 2. 97 μg/L) ] (P =0. 040). Multivariate linear regression analysis showed serum visfatin level was affected by high-sensitivity C-reactive protein ( hs- CRP) in the chronic SCAD group (13 = 0. 458, 95% CI 0. 065-0. 308, P = 0. 004). Logistic regression analysis revealed that serum visfatin level was an independent risk factor for chronic SCAD ( OR 2. 086, 95% CI 1. 046-4. 160, P =0. 037). Conclusion Serum visfatin level is significantly elevated in patients with chronic SCAD, which may be closely related to the occurrence of the disease.
出处 《中国动脉硬化杂志》 CAS 北大核心 2016年第1期67-71,共5页 Chinese Journal of Arteriosclerosis
基金 首都医科大学基础临床科研合作基金资助项目(12JL57)
关键词 内脂素 慢性稳定性冠心病 相关性 Visfatin Chronic Stable Coronary Artery Disease Correlation
  • 相关文献

参考文献9

  • 1Montecucco F, Cea M, Cagnetta A, et al. Nicotinamide phosphoribosyl transferase as a target in inflammation-relat- ed disorders[J]. Curr Top Med Chem, 2013, 13(23) : 2 930-938.
  • 2Dalai TB, Yndestad A, Skjelland M, et al. Increased ex- pression of visfatin in macrophages of human unstable ca-rotid and coronary atherosclerosis: possible role in inflam- mation and plaque destabilization [ J ]. Circulation, 2007, 115 (8) : 972-950.
  • 3中国心血管病预防指南[J].中华心血管病杂志,2011,39(1):3-22. 被引量:640
  • 4Fukuhara A, Matsuda M, Nishizawa M, et al. Visfatin: a protein secreted by visceral fat that mimics the effects of in- sulin[J]. Science, 2005, 307(5708):426-430.
  • 5Spiroglou SG, Kostopoulos CG, Varakis JN, et al. Adipo- kines in periaortie and epicardial adipose tissue: differenti- al expression and relation to atherosclerosis [ J ]. J Athero- scler Thromb, 2010, 17(2) : 115-130.
  • 6Kadoglou NP, Gkontopoulos A, Kapelouzou A, et al. Ser- um levels of vaspin and visfatin in patients with coronary artery disease-Kozani study[ J]. Clin Chim Aeta, 2011, 412(1-2) : 48-52.
  • 7Choi KM, Lee JS, Kim EJ, et al. Implication of lipocalin- 2 and visfatin levels in patients with coronary heart disease [J]. Eur J Endocrinol, 2008, 158(2) : 203-207.
  • 8Chang YC, Chang TJ, Lee WJ, et al. The relationship of visfatin/pre-B-cell colony-enhancing factor/nicotinamide phosphoribosyl transferase in adipose tissue with inflamma- tion, insulin resistance, and plasma lipids [ J ]. Metabo- lism, 2010, 59(1) : 93-99.
  • 9江高峰,秦旭平,李洁.免疫炎症反应在动脉粥样硬化中作用的研究进展[J].中南医学科学杂志,2015,43(2):212-216. 被引量:18

二级参考文献38

共引文献656

同被引文献85

  • 1中华医学会神经病学分会脑血管病学组急性缺血性脑卒中诊治指南撰写组.中国急性缺血性脑卒中诊治指南2010[J].中国医学前沿杂志(电子版),2010,2(4):50-59. 被引量:1834
  • 2刘兰,黄岚.心血管危险因素对颈动脉粥样硬化的影响及超声评价的意义[J].心血管病学进展,2007,28(1):139-142. 被引量:24
  • 3Wang L S,Yan J J,Tang N P,et al.A polymorphism in the visfatin gene promoter is related to decreased plasma levels of inflammatory markers in patients with coronary artery disease[J].Mol Biol Rep,2011,38(2):819-825.
  • 4Li H,Horke S,Frstermann U.Vascular oxidative stress,nitric oxide and atherosclerosis[J].Atherosclerosis,2014,237(1):208-219.
  • 5Lu Y C,Hsu C C,Yu T H,et al.Association between visfatin levels and coronary artery disease in patients with chronic kidney disease[J].Iran J Kidney Dis,2013,7(6):446-452.
  • 6Laiguillon M C,Houard X,Bougault C,et al.Expression and function of visfatin(Nampt),an adipokine-enzyme involved in inflammatory pathways of osteoarthritis[J].Arthritis Res Ther,2014,16(1):R38-43.
  • 7Yuan S S F,Hung A C,Hou M F.Abstract 434:Circulating visfatin promotes malignant cancer behavior through activation of STAT3 signaling in breast cancer:Table 1.[J].Cancer Research,2014,74(19):434-434.
  • 8Fukuhara A,Matsuda M,Nishizawa M,et al.Visfatin:a protein secreted by visceral fat that mimics the effects of insulin[J].Science,2005,307(5708):426-430.
  • 9HulejováH,KrytfkováO,Mann H,et al.Increased visfatin levels are associated with higher disease activity in anti-Jo-1-positive myositis patients[J].Clin Exp Rheumatol,2016,34(2):222-229.
  • 10Adya R,Tan BK,Punn A,et al.Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways:novel insights into visfatin-induced angiogenesis[J].Cardiovasc Res,2008,78(2):356.

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部